在高血压中优化药物坚持:不仅仅是一个思维游戏
Tom Robberechts1,2, Maria S Stoenoiu3, Michel Burnier4
1Department of Nephrology and Hypertension, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Kardiologia polska
|March 15, 2024
概括
血压药物和生活方式变化的不良坚持显著影响全球治疗结果. 本综述强调了影响患者和医生遵守规定的心理因素,这对于改善血压控制至关重要.
科学领域:
- 心脏病学和公共卫生
- 专注于心血管健康管理和人口层面的健康行为之间的交集.
背景情况:
- 对抗高血压药物和生活方式建议的不充分遵守是全球不受控制的高血压的主要驱动因素.
- 违规率差异很大,可能影响高达40%的患者,但由于医生诊断工具有限,往往仍未被诊断出来.
研究的目的:
- 为5个关键方面的药物和生活方式的不坚持提供一个实际的审查.
- 从患者和医生的角度强调影响遵守的心理因素.
主要方法:
- 文献综述侧重于非坚持的实际方面.
- 对坚持模式的心理影响的分析.
- 检查患者和医生的观点.
主要成果:
- 不遵守是全球高血压管理的重要障碍.
- 心理因素在患者和医生遵守行为中起着至关重要的作用.
- 目前的诊断工具不足以进行可靠的评估.
结论:
- 解决不服从需要更深入地了解心理影响患者和医生行为的心理影响.
- 需要改进的诊断工具和专注于心理方面的策略,以加强血压控制.
- 实际方法对于克服药物治疗和生活方式的障碍至关重要.
相关概念视频
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
Antihypertensive Drugs: Direct Renin Inhibitors
621
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
621
Antihypertensive Drugs: Action of Diuretics
680
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
680
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
631
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
631
Antihypertensive Drugs: Vasodilators
516
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
516


